tradingkey.logo

Globus Medical Inc

GMED

57.900USD

+0.060+0.10%
Horário de mercado ETCotações atrasadas em 15 min
7.82BValor de mercado
21.92P/L TTM

Globus Medical Inc

57.900

+0.060+0.10%
Mais detalhes de Globus Medical Inc Empresa
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions with a focus on improving the quality of life of patients with musculoskeletal disorders. The Company offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the majority of conditions affecting the spine, including degenerative conditions, deformity, tumors, and trauma. It provides solutions that facilitate both open and minimally invasive surgery (MIS) techniques. It includes traditional fusion implants, such as pedicle screws and rod systems. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.
Informações da empresa
Código da empresaGMED
Nome da EmpresaGlobus Medical Inc
Data de listagemMar 08, 2012
CEOMr. Keith W. Pfeil
Número de funcionários5300
Tipo de títulosOrdinary Share
Fim do ano fiscalMar 08
Endereço2560 General Armistead Ave
CidadeAUDUBON
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal19403
Telefone16109301800
Sitehttps://www.globusmedical.com/
Código da empresaGMED
Data de listagemMar 08, 2012
CEOMr. Keith W. Pfeil
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. David D. Davidar
Mr. David D. Davidar
Independent Director
Independent Director
685.24K
-6.86%
Ms. Ann D. Rhoads
Ms. Ann D. Rhoads
Independent Director
Independent Director
35.38K
--
Mr. Daniel J. Wolterman
Mr. Daniel J. Wolterman
Independent Director
Independent Director
24.02K
--
Ms. Leslie V. Norwalk
Ms. Leslie V. Norwalk
Independent Director
Independent Director
16.42K
--
Mr. Robert Andrew (Rob) Douglas
Mr. Robert Andrew (Rob) Douglas
Independent Director
Independent Director
2.00K
--
Mr. Brian Kearns
Mr. Brian Kearns
Investor Relations
Investor Relations
--
--
Mr. Stephen T. (Steve) Zarrilli
Mr. Stephen T. (Steve) Zarrilli
Independent Director
Independent Director
--
--
Mr. James R. Tobin
Mr. James R. Tobin
Independent Director
Independent Director
--
--
Ms. Kelly Grace Huller, J.D.
Ms. Kelly Grace Huller, J.D.
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
--
--
Dr. John A. Deford, Ph.D.
Dr. John A. Deford, Ph.D.
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. David D. Davidar
Mr. David D. Davidar
Independent Director
Independent Director
685.24K
-6.86%
Ms. Ann D. Rhoads
Ms. Ann D. Rhoads
Independent Director
Independent Director
35.38K
--
Mr. Daniel J. Wolterman
Mr. Daniel J. Wolterman
Independent Director
Independent Director
24.02K
--
Ms. Leslie V. Norwalk
Ms. Leslie V. Norwalk
Independent Director
Independent Director
16.42K
--
Mr. Robert Andrew (Rob) Douglas
Mr. Robert Andrew (Rob) Douglas
Independent Director
Independent Director
2.00K
--
Mr. Brian Kearns
Mr. Brian Kearns
Investor Relations
Investor Relations
--
--
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
Musculoskeletal Solutions
575.93M
96.29%
Musculoskeletal Solutions products
575.93M
96.29%
Enabling Technologies
22.19M
3.71%
Enabling Technologies products
22.19M
3.71%
Por RegiãoUSD
Nome
Receita
Proporção
United States
483.86M
80.90%
International
114.26M
19.10%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Musculoskeletal Solutions
575.93M
96.29%
Musculoskeletal Solutions products
575.93M
96.29%
Enabling Technologies
22.19M
3.71%
Enabling Technologies products
22.19M
3.71%
Distribuição de ações
Atualizado em: sáb, 16 de ago
Atualizado em: sáb, 16 de ago
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
9.49%
BlackRock Institutional Trust Company, N.A.
8.71%
Janus Henderson Investors
7.29%
Burgundy Asset Management Ltd.
3.09%
State Street Global Advisors (US)
3.08%
Outro
68.34%
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
9.49%
BlackRock Institutional Trust Company, N.A.
8.71%
Janus Henderson Investors
7.29%
Burgundy Asset Management Ltd.
3.09%
State Street Global Advisors (US)
3.08%
Outro
68.34%
Tipos de investidores
Investidores
Proporção
Investment Advisor
51.77%
Investment Advisor/Hedge Fund
35.75%
Hedge Fund
10.02%
Pension Fund
1.99%
Research Firm
1.43%
Sovereign Wealth Fund
1.07%
Bank and Trust
1.07%
Individual Investor
0.69%
Private Equity
0.29%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
1034
115.30M
102.09%
-12.49M
2025Q1
1057
115.54M
102.35%
-11.15M
2024Q4
1031
113.94M
83.15%
-12.71M
2024Q3
978
112.33M
98.84%
-21.04M
2024Q2
969
117.21M
103.71%
-15.66M
2024Q1
950
117.87M
104.30%
-9.50M
2023Q4
917
111.19M
96.81%
-13.25M
2023Q3
911
113.44M
96.67%
+12.22M
2023Q2
864
84.90M
108.73%
-4.84M
2023Q1
857
78.38M
100.58%
-6.61M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
The Vanguard Group, Inc.
10.88M
9.64%
+45.25K
+0.42%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
9.87M
8.73%
+23.63K
+0.24%
Mar 31, 2025
Janus Henderson Investors
7.01M
6.2%
+391.41K
+5.92%
Mar 31, 2025
Burgundy Asset Management Ltd.
2.80M
2.48%
+183.64K
+7.01%
Mar 31, 2025
State Street Global Advisors (US)
3.62M
3.2%
+21.05K
+0.59%
Mar 31, 2025
JP Morgan Asset Management
2.45M
2.17%
-176.33K
-6.72%
Mar 31, 2025
Sculptor Capital Management, Inc
2.09M
1.85%
+15.00K
+0.72%
Mar 31, 2025
William Blair Investment Management, LLC
2.27M
2.01%
+1.04M
+84.46%
Mar 31, 2025
Hawk Ridge Capital Management LP
1.68M
1.49%
+4.56K
+0.27%
Mar 31, 2025
Geneva Capital Management LLC
1.83M
1.62%
+17.81K
+0.98%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 6 de set
Atualizado em: sáb, 6 de set
Nome
Proporção
First Trust Indxx Medical Devices ETF
1.62%
ProShares MSCI Transformational Changes ETF
0.2%
Strive 1000 Growth ETF
0.01%
AvantisUS Mid Cap Value ETF
0.01%
Vanguard US Momentum Factor ETF
0%
Vanguard S&P Mid-Cap 400 Value Index Fund
0%
Inspire Small/Mid Cap ESG ETF
0%
John Hancock Multifactor Small Cap ETF
0%
First Trust Mid Cap Core Alphadex Fund
0%
First Trust Mid Cap Value AlphaDEX Fund
0%
Ver Mais
First Trust Indxx Medical Devices ETF
Proporção1.62%
ProShares MSCI Transformational Changes ETF
Proporção0.2%
Strive 1000 Growth ETF
Proporção0.01%
AvantisUS Mid Cap Value ETF
Proporção0.01%
Vanguard US Momentum Factor ETF
Proporção0%
Vanguard S&P Mid-Cap 400 Value Index Fund
Proporção0%
Inspire Small/Mid Cap ESG ETF
Proporção0%
John Hancock Multifactor Small Cap ETF
Proporção0%
First Trust Mid Cap Core Alphadex Fund
Proporção0%
First Trust Mid Cap Value AlphaDEX Fund
Proporção0%
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI